NanoCellect Biomedical announces distribution to Korea

 NanoCellect Biomedical in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, announced the selection of Seoul-based DAON BioSciences as exclusive distributor in the South Korea market. DAON is a distributor of instruments, reagents and software to the Korean biotechnology research market.

Korea is a key area of growth for NanoCellect, and working with DAON was an obvious choice for us,” said Chris Neary, CEO of NanoCellect. “We believe that our products complement their current portfolio and will greatly enhance their ability to improve the research workflows for their customers. We were also impressed with the positive feedback from their existing partners and customers in Korea, describing the high level of technical support and professionalism from the team at DAON.”

We are pleased to be adding NanoCellect’s cell sorting solutions to our portfolio,” said Sujin Kim, CEO at DAON. “NanoCellect’s WOLF platform will enable our customers to significantly advance their research by providing gentle cell sorting in sterile microfluidic cartridges. The WOLF platform will address an unmet need of many of our research customers, advancing single cell genomics and cloning applications in Korea.”